NYSE:VAPO (USA) Also Trade In: Germany
Vapotherm Inc $ 31.98 -0.18 (-0.56%)
Warning! GuruFocus has detected 2 Severe warning signs with VAPO. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for VAPO (Vapotherm Inc) from 2018 to Jan 20 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Vapotherm stock (VAPO) PE ratio as of Jan 20 2021 is 0. More Details
Vapotherm PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Vapotherm PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:SIBN NAS:OFIX NAS:ZYXI NAS:GNMK NAS:ESTA NAS:VREX NAS:XENT NAS:NTUS NAS:QTRX NAS:CTSO NYSE:ABT NYSE:MDT NYSE:SYK NYSE:BSX SZSE:300760 NYSE:EW NYSE:ZBH NAS:ALGN LSE:SN. NYSE:BIO
Address 100 Domain Drive, Exeter, NH, USA, 03833
Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress. The company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox. It generates revenue primarily from sales of proprietary Precision Flow systems to hospitals through a direct sales organization in the United States and distributors in select countries outside of the United States.